Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Tessera Therapeutics
company
Funding Round
Series C
Money Raised
$ 300M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Abu Dhabi Investment Authority | - | - | - | Detail |
| Alaska Permanent Fund | - | - | - | Detail |
| Altitude Life Science Ventures | - | - | - | Detail |
| Artis Ventures (AV) | - | - | - | Detail |
| Cormorant Asset Management | - | - | - | Detail |
| Flagship Pioneering | - | - | - | Detail |
| Hanwha Impact Partners | - | - | - | Detail |
| Longevity Vision Fund | - | - | - | Detail |
| March Capital | - | - | - | Detail |
| SALT Fund | - | - | - | Detail |
| SoftBank Vision Fund | - | - | - | Detail |
| T. Rowe Price | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| May 7, 2020 | Seed | $ 2.70M | Detail | |
| Jan 12, 2021 | Series B | $ 230M | Alaska Permanent Fund,Altitude Life Science Ventures,etc. | Detail |
